BPTH delays Q3 2025 Form 10-Q, cites management change

Rhea-AI Filing Summary

Bio-Path Holdings, Inc. filed a Form 12b-25 to notify the SEC and investors that its Form 10-Q for the quarter ended September 30, 2025 will be filed late. The company states it is still compiling the necessary information for the quarterly report and that all information has not yet been received due to a change in management. Bio-Path indicates it expects to file the Form 10-Q within the permitted grace period after the original due date.

Insights

Equity disclosure analyst

Bio-Path discloses a late 10-Q tied to management changes.

Bio-Path Holdings, Inc. has submitted a Form 12b-25 indicating its Form 10-Q for the quarter ended September 30, 2025 will not be filed on time. The reason given is that information needed for the report is still being compiled and has not all been received following a change in management.

The company also indicates that the Form 10-Q will be filed within the standard extension window allowed under Rule 12b-25. This suggests the delay is expected to be temporary, though actual timing will be confirmed once the 10-Q is filed.

Form 12b-25 notifications are relatively common, but they can signal operational or reporting complexity, especially when linked to leadership transitions. The eventual 10-Q for the period ended September 30, 2025 will provide the first detailed view of any financial or operational shifts following the change in management.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR

For the Period Ended: September 30, 2025

☐ Transition Report on Form 10-KSB

☐ Transition Report on Form 10-QSB

☐ Transition Report on Form 20-F

☐ Transition Report on Form N-SAR

☐ Transition Report on Form 11-K

For the Transition Period Ended:

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Full Name of Registrant: Bio-Path Holdings, Inc.

Former Name, if Applicable: Not Applicable:

Address of Principal Executive Office (Street and Number):

625 Stanwix St. #2407

Pittsburgh, PA 15222

PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without reasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

☐ (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

☐ (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable)

PART III - NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Registrant is in the process of compiling information for the quarter ending September 30, 2025 for the Form 10-Q, all of which information has not yet been received due to change in management.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification:

	Vikram Grover		630		708-0750
	(Name)		(Area Code)		(Telephone Number)

(2) Have all or other periodic report required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

☐ Yes ☒ No

The Registrant has caused this notification to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIO-PATH HOLDINGS, INC.
Dated: November 17, 2025	By:	/s/ Vikram Grover
		Vikram Grover
		Chief Executive Officer, Chief Financial Officer and Director

FAQ

Why did Bio-Path Holdings (BPTH) file a Form 12b-25 for its Q3 2025 10-Q?

Bio-Path Holdings filed Form 12b-25 because it could not complete its Form 10-Q for the quarter ended September 30, 2025 on time. The company states it is still compiling required information and that all of it has not yet been received due to a change in management.

Which period does Bio-Path Holdings' delayed Form 10-Q cover?

The delayed Form 10-Q for Bio-Path Holdings covers the fiscal quarter ended September 30, 2025.

Will Bio-Path Holdings (BPTH) still file its Q3 2025 Form 10-Q?

Yes. In the Form 12b-25, Bio-Path Holdings indicates that the Form 10-Q for the quarter ended September 30, 2025 will be filed within the extension period allowed under SEC rules.

What reason did Bio-Path give for the late filing of its Form 10-Q?

The company explains that it is in the process of compiling information for the quarter ended September 30, 2025 and that all information has not yet been received because of a change in management.

Does Bio-Path expect significant changes in results of operations in the delayed 10-Q?

In response to the standard question on Form 12b-25, Bio-Path indicated whether it anticipates any significant change in results of operations to be reflected in the earnings statements in the upcoming Form 10-Q, but no specific figures or details are provided in the excerpt.

Who signed Bio-Path Holdings' Form 12b-25 notification?

The Form 12b-25 was signed on behalf of Bio-Path Holdings, Inc. by Vikram Grover, who is identified as Chief Executive Officer, Chief Financial Officer and Director.